NCT05004584

Brief Summary

The overall aim is to investigate whether there is a difference between methods when a standardized visual analogue scale is used to measure appetite in the home-setting compared to a monitored clinical setting. Furthermore, the intention is to investigate differences in appetite response between diets based on rye or wheat products, as well as the effects on postprandial metabolic response to such diets. Lastly, the effect of venous blood collection on subjective appetite response will be evaluated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 16, 2021

Completed
28 days until next milestone

First Posted

Study publicly available on registry

August 13, 2021

Completed
18 days until next milestone

Study Start

First participant enrolled

August 31, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 16, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 16, 2021

Completed
Last Updated

December 15, 2021

Status Verified

December 1, 2021

Enrollment Period

3 months

First QC Date

July 16, 2021

Last Update Submit

December 14, 2021

Conditions

Keywords

Visual analogue scale (VAS)Continuous glucose monitors (CGM)

Outcome Measures

Primary Outcomes (3)

  • Appetite assessment: hunger

    Appetite will be measured through visual analogue scales 1-100mm, filled in by the participants throughout the assessment days.

    Throughout the appetite assessment days ,13 hours.

  • Appetite assessment: fullness

    Appetite will be measured through visual analogue scales 1-100mm, filled in by the participants throughout the assessment days.

    Throughout the appetite assessment days ,13 hours.

  • Appetite assessment: desire to eat

    Appetite will be measured through visual analogue scales 1-100mm, filled in by the participants throughout the assessment days.

    Throughout the appetite assessment days ,13 hours.

Secondary Outcomes (12)

  • Body weight

    Through study completion, an average of 5 weeks.

  • Height

    Height is measured at baseline.

  • Continuous glucose measurement

    Throughout the appetite assessment days ,13 hours.

  • Physical activity

    Throughout the appetite assessment days ,13 hours.

  • Postprandial glucose response

    Throughout the appetite assessment days ,13 hours.

  • +7 more secondary outcomes

Study Arms (5)

Wheat home-based

EXPERIMENTAL
Other: Wheat home-based appetite assessment

Rye home-based

EXPERIMENTAL
Other: Rye home-based appetite assessment

Rye clinic-based

EXPERIMENTAL
Other: Rye clinic-based appetite assessment

Wheat clinic-based

EXPERIMENTAL
Other: Wheat clinic-based appetite assessment

Wheat/Rye clinic-based with blood sampling

EXPERIMENTAL
Other: Rye/Wheat clinic-based appetite assessment with blood sampling

Interventions

Home-based appetite assessment with diet based on wheat cereal products.

Wheat home-based

Home-based appetite assessment with diet based on rye cereal products.

Rye home-based

Clinic-based appetite assessment with diet based on wheat cereal products.

Wheat clinic-based

Clinic-based appetite assessment with diet based on rye cereal products.

Rye clinic-based

Clinic-based appetite assessment with diet based on rye or wheat cereal products and continuous blood sampling.

Wheat/Rye clinic-based with blood sampling

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women
  • Age 30-70 years
  • Body mass index (BMI) 27-35 kg/m2
  • Hemoglobin ≥117g/l for women and for men ≥134g/l
  • Thyroid stimulating hormone (TSH) ≤4.30 mIU/L
  • Low density lipoprotein (LDL) cholesterol ≤5.30 mmol/L
  • Triglycerides ≤2.60 mmol/L
  • Signed informed consent
  • Having a mobile device, laptop or similar with internet connection. As well as an email, that they are willing to use for answering questions online, both at the clinic and at home.

You may not qualify if:

  • Blood donation or participation in a clinical study with blood sampling within 30 days prior to screening visit and throughout the study
  • Using nicotine products on a daily basis (incl. chewing gum, patches, snus etc.)
  • Using e-cigarettes (regardless of nicotine content)
  • Following any weight reduction program or having followed one during the last 6 months prior to screening.
  • Diastolic blood pressure ≥ 105 mm Hg at screening
  • Systolic blood pressure ≥ 160 mm at screening
  • History of stomach or gastrointestinal conditions (Inflammatory bowel disease, Crohn's disease, malabsorption, colostomy, bowel resection, gastric bypass surgery etc.)
  • More than 10 hours physical activity per week (e.g. sport, fitness or similar).
  • History of heart failure or heart attack within 1 year prior to screening
  • Having type-I diabetes
  • Receiving pharmacological treatment for type-II diabetes
  • Previous gastrointestinal surgery, with the exception of minor surgeries such removal of appendix or gall bladder at least 6 months prior to screening.
  • Thyroid disorder
  • History of drug or alcohol abuse
  • Stroke or transient ischemic attack (TIA) within 1 year prior to screening
  • +5 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Gothenburg, Department of Food and Nutrition and Sport Science

Gothenburg, 41251, Sweden

Location

Related Publications (1)

  • Aberg S, Webb DL, Nordin E, Hellstrom PM, Landberg R. Postprandial Effects of Four Test Meals Containing Wholegrain Rye or Refined Wheat Foods on Circulating Incretins, Ghrelin, Glucose, and Inflammatory Markers. J Nutr. 2025 Jan;155(1):185-196. doi: 10.1016/j.tjnut.2024.10.046. Epub 2024 Nov 6.

MeSH Terms

Conditions

OverweightObesityAppetitive Behavior

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior, AnimalBehavior

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Rikard Landberg, Dr

    Chalmers University of Technology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of division of Food and Nutrition Science, Professor Rikard Landberg,

Study Record Dates

First Submitted

July 16, 2021

First Posted

August 13, 2021

Study Start

August 31, 2021

Primary Completion

November 16, 2021

Study Completion

November 16, 2021

Last Updated

December 15, 2021

Record last verified: 2021-12

Locations